Literature DB >> 6367444

Controlling financial variables--changing prescribing patterns.

P W Abramowitz.   

Abstract

Techniques of formulary management, pharmacy and therapeutics committee intervention, and the use of clinical pharmacy services to change prescribing patterns and contain costs in hospital pharmacy departments are reviewed. Methods of using the formulary to contain costs include deletion of generic and therapeutic equivalents, inclusion of therapeutic categories and cost codes, and regular reviews and updates of its contents. Drug monographs for formulary evaluation prepared for the P & T committee should include a comparative review of other drugs in the therapeutic category and a cost impact statement. The P & T committee can help contain costs by developing policies for automatic stop orders and restricted drug use. Clinical pharmacy activities that can result in cost savings include physician education (focused on prescribing), target drug programs, target disease programs, pharmacist participation on TPN and i.v. therapy teams, and patient training programs for home care. A matrix for evaluating cost-containment activities is presented. By tailoring the described methods to departmental personnel resources and hospital needs, the pharmacy can be effective in controlling costs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6367444

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  10 in total

1.  Should hospital pharmacy drug budgets be the responsibility of each individual department in an institution, or should such budgets be controlled centrally by the pharmacy department?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-07

2.  Drug cost containment at a large teaching hospital.

Authors:  P I Pillans; I Conry; B E Gie
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 3.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

4.  A review of limited lists and formularies: are they cost-effective?

Authors:  M J Pearce; E J Begg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

5.  Prioritising drug and therapeutics committee (DTC) decisions: a national survey.

Authors:  Ee Lyn Tan; Richard O Day; Jo-anne E Brien
Journal:  Pharm World Sci       Date:  2006-12-23

6.  Initiation of clinical pharmacy in Greece.

Authors:  F Stathoulopoulou; L Papastamatiou; L Lapidakis
Journal:  Pharm World Sci       Date:  1996-12

7.  Quality control of hospital formularies.

Authors:  T D Rucker
Journal:  Pharm Weekbl Sci       Date:  1988-08-19

8.  The effects of a low-cost intervention program on hospital costs.

Authors:  J E Billi; L Duran-Arenas; C G Wise; A M Bernard; M McQuillan; J K Stross
Journal:  J Gen Intern Med       Date:  1992 Jul-Aug       Impact factor: 5.128

9.  What Is a Formulary, Anyway? Part 2.

Authors:  Richard H Parrish
Journal:  Pharmacy (Basel)       Date:  2018-07-23

10.  Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency.

Authors:  Niaz Deyhim; Amanda Beck; Jonathan Balk; Michael G Liebl
Journal:  Clinicoecon Outcomes Res       Date:  2020-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.